Skip to main content

Advertisement

Log in

Estimating prevalence of functional iron deficiency anaemia in advanced cancer

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

Anaemia is a common complication of cancer causing symptoms including fatigue. It is also associated with shorter survival. Cancer causes systemic inflammation which interrupts iron metabolism leading to a functional iron deficiency (FID). There are few data on prevalence or aetiology of anaemia in those with advanced cancer. We aimed to establish the prevalence of anaemia and estimate extent of FID anaemia in patients with advanced cancer.

Methods

All patients with advanced cancer referred to two UK specialist palliative care services over 1 year were identified. Demographic and clinical data were linked with routinely collected haematological and biochemical profiles. We assessed the numbers of patients with abnormal values for haemoglobin, % hypochromic red cells (>5% indicates iron-restricted erythropoiesis) and CRP (>10 indicates systemic inflammation). We judged that FID anaemia was likely when patients had all three abnormalities and ferritin 30–800 ng/ml.

Results

Out of 2416 patients, 1797 had a cancer diagnosis and laboratory data available. Mean haemoglobin was 116 g/l. Sixty-three percent of patients were anaemic, mild 25%, moderate 35% and severe 3%. Women had significantly higher mean haemoglobin than men, and there was wide variation in anaemia prevalence across tumour sites. Thirty-nine percent of patients who had all four parameters checked met our criteria for FID anaemia. There were significant relationships between haemoglobin, % hypochromic red cells and CRP (p = 0.0001).

Conclusions

Anaemia was common in this population, and we estimate this was caused by FID in 66% of anaemic patients. Further research is needed to validate our diagnostic criteria before this approach can be used in clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Magnusson K, Möller A, Ekman T, Wallgren A (1999) A qualitative study to explore the experience of fatigue in cancer patients. European Journal of Cancer Care 8(4):224–232

    Article  CAS  Google Scholar 

  2. Ludwig H, Müldür E, Endler G, Hüb W (2013) Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia. Ann Oncol 24(7):1886–1892

    Article  CAS  Google Scholar 

  3. Ludwig H, Van Belle S, Barrett-Lee P, Birgegård G, Bokemeyer C, Gascón P, Kosmidis P, Krzakowski M, Nortier J, Olmi P, Schneider M, Schrijvers D (2004) The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer Oct 40(15):2293–2306

    Article  Google Scholar 

  4. Dunn A, Carter J, Carter H (2003) Anemia at the end of life: prevalence, significance, and causes in patients receiving palliative care. J Pain Symptom Manag 26(6):1132–1139

    Article  Google Scholar 

  5. Young B, Zaritsky J (2009) Hepcidin for clinicians. Clin J Am Soc Nephrol 4:1384–1387

    Article  CAS  Google Scholar 

  6. Bergamaschi G, Villani L (2009) Serum hepcidin: a novel diagnostic tool in disorders of iron metabolism. Haematol 94(12):1631–1633 www.haematologica.org/content/94/12/1631/F1.expansion

    Article  CAS  Google Scholar 

  7. Sun CC, Vaja V, Babitt JL, Lin HY (2012) Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation. Am J Hematol 87(4):392–400

    Article  CAS  Google Scholar 

  8. Thomas DW, Hinchliffe RF, Briggs C, Macdougall IC, Littlewood T, Cavill I, British Committee for Standards in Haematology (2013) Guideline for the laboratory diagnosis of functional iron deficiency. Br J Haematol 161:639–648

    Article  CAS  Google Scholar 

  9. Gilreath JA, Stenehjem DD, Rodgers GM (2014) Diagnosis and treatment of cancer-related anemia. Am J Hematol 89(2):203–212

    Article  Google Scholar 

  10. Caro JJ, Salas M, Ward A, Goss G (2001) Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 91(12):2214–2221

    Article  CAS  Google Scholar 

  11. World Health Organisation (2011) Haemoglobin concentrations for the diagnosis and assessment of severity. [Online]. [Accessed 28 August 2013]. Available from: http://www.who.int/vmnis/indicators/haemoglobin.pdf

  12. Eklund CM (2009) Proinflammatory cytokines in CRP baseline regulation. Adv Clin Chem 48:111–136

    Article  CAS  Google Scholar 

  13. CRP [Online] [Accessed 23 March 2016] Available from: http://emedicine.medscape.com/article/2086909-overview

  14. Bovy C, Gothot A, Delanaye P, Warling X, Krzesinski JM, Beguin Y (2007) Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity. Nephrol Dial Transplant 22(4):1156–1162

    Article  CAS  Google Scholar 

  15. Murphy PT, Quinn JP, O'Donghaile D, Swords R, O'Donnell JR (2006) Myelodysplastic patients with raised percentage of hypochromic red cells have evidence of functional iron deficiency. Ann Hematol 85(7):455–457

    Article  CAS  Google Scholar 

  16. Thomas C, Thomas L (2002) Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem 48(7):1066–1076

    CAS  PubMed  Google Scholar 

  17. Robertson KA, Hutchinson SM (2009) Assessment of iron status and the role for iron replacement therapy in anaemic cancer patients under the care of a specialist palliative care unit. Palliat Med 23:406–409

    Article  CAS  Google Scholar 

  18. Hoffbrand AV, Hershko C, Camaschella C (2011) Iron metabolism, iron deficiency and disorders of haem synthesis. In: Hoffbrand AV, Catovsky D, Tuddenham EGD, Green AR (eds) Postgraduate haematology: 6th edition. Blackwell, London, pp. 26–46

    Google Scholar 

  19. Bach V, Schruckmayer G, Sam I, Kemmler G, Stauder R (2014) Prevalence and possible causes of anemia in the elderly: a cross-sectional analysis of a large European university hospital cohort. Clinical Interventions In Aging 9:1187–1196

    PubMed  PubMed Central  Google Scholar 

  20. Ludwig H, Evstatiev R, Kornek G, Aapro M, Bauernhofer T, Buxhofer-Ausch V, Fridrik M, Geissler D, Geissler K, Gisslinger H, Koller E, Kopetzky G, Lang A, Rumpold H, Steurer M, Kamali H, Link H (2015) Iron metabolism and iron supplementation in cancer patients. Wien Klin Wochenschr 127:907–919

    Article  CAS  Google Scholar 

  21. Hedenus M, Karlsson T, Ludwig H, Rzychon B, Felder M, Roubert B, Birgegård G (2014) Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy. Med Oncol 31(12):302

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karen Neoh.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Appendix 1

Appendix 1

Table 5 Normal values of recorded parameters

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Neoh, K., Stanworth, S., Pasricha, SR. et al. Estimating prevalence of functional iron deficiency anaemia in advanced cancer. Support Care Cancer 25, 1209–1214 (2017). https://doi.org/10.1007/s00520-016-3511-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-016-3511-9

Keywords

Navigation